
Opinion|Videos|August 23, 2024
Comparing Biologics and Biosimilars
Author(s)Sophia Humphreys, PharmD, MHA
Sophia Humphreys, PharmD, MHA, BCBBS, discusses the key differences between biologics and biosimilars.
Advertisement
Episodes in this series

Now Playing
Video content above is prompted by the following:
- What are key differences between biologics and biosimilars in terms of safety, efficacy, and FDA approval, and what sets biosimilars apart from one another?
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
3
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
4
Balancing Survival and Quality of Life in Pancreatic Cancer: Expert Perspectives From an Immuneering Panel
5






















